(firstQuint)Anfibatide Phase Ib-IIa Clinical Trial.

 1.

 This study is a phase Ib-IIa exploratory study to observe the safety of Antiplatelet Thrombolysin for Injection for the treatment of non-ST segment myocardial infarction (NSTEMI) patients and preliminarily evaluate the efficacy of different doses, providing the theoretical basis of the phase II and III clinical study protocol.

 2.

 To investigate the pharmacokinetics of different doses.

.

 Anfibatide Phase Ib-IIa Clinical Trial@highlight

Investigate the safety and efficacy of Anfibatide in non-ST segment myocardial infarction patients